Table 3.
Model 1 |
Model 2 |
|||||
---|---|---|---|---|---|---|
Characteristic | RR | 95%CI | p | RR | 95%CI | p |
Age, years | 1.02 | 0.97, 1.06 | 0.332 | 1.03 | 0.98, 1.07 | 0.140 |
Hypertension | 1.32 | 0.83, 2.96 | 0.420 | 1.33 | 0.44, 1.89 | 0.470 |
Type 2 diabetes | 1.98 | 0.40, 9.76 | 0.401 | 1.17 | 0.23, 6.04 | 0.843 |
Obesity | 2.01 | 0.82, 4.88 | 0.122 | 1.82 | 0 .74, 4.48 | 0.190 |
Basal VD deficiency | 0.86 | 0.35, 2.10 | 0.756 | 1.42 | 0.56, 3.56 | 0.450 |
VDGb | 0.22 | 0.09, 0.56 | 0.001 | - | - | - |
25-hydroxyvitamin D3, deltasc | - | - | - | 0.87 | 0.82, 0.93 | 0.001 |
Logistic regression analysis, adjusted by type of personnel and hospital.
Compared with PG.
Deltas are the difference between final and basal concentration.
95%CI, 95% confidence interval; VD, vitamin D; VDG, vitamin D supplemented group; PG, placebo group.